AF
Andrew Fein HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
158
Avg Return
Past Year
Past Year
25%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
81%
Neutral
19%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $18 |
102%
upside
| 2 | +6.5% |
0
%
| 24 Nov ‘25 11 days ago |
|
|
|
Buy
Maintained
| $620 |
7%
upside
| 2 | +9.9% |
0
%
| 21 Nov ‘25 14 days ago |
|
|
|
Neutral
Maintained
| $9 |
26%
upside
| 2 | -30% |
0
%
| 11 Nov ‘25 24 days ago |
|
|
|
Buy
Maintained
| $20 |
41%
upside
| 1 | +49% |
0
%
| 7 Nov ‘25 28 days ago |
|
|
|
Buy
Maintained
| $30 |
171%
upside
| 2 | -0.6% |
0
%
| 7 Nov ‘25 28 days ago |
|
|
|
Buy
Maintained
| $190 |
89%
upside
| 2 | +31% |
0
%
| 6 Nov ‘25 29 days ago |
|
|
|
Buy
Maintained
| $84 |
26%
upside
| 2 | +23% |
0
%
| 5 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $50 |
45%
upside
| 2 | +19% |
0
%
| 4 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $525 |
7%
upside
| 2 | +10% |
0
%
| 30 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $20 |
44%
upside
| 1 | +32% |
0
%
| 29 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $5 |
310%
upside
| 1 | +36% |
0
%
| 22 Oct ‘25 1 month ago |
|
|
|
Neutral
Downgraded
| $54 |
1%
downside
| 1 | +19% |
0
%
| 10 Oct ‘25 1 month ago |
|
|
|
Neutral
Downgraded
| $14.50 | – | 1 | +62% |
0
%
| 19 Sep ‘25 2 months ago |
|